Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Avismo Ventures is a venture capital firm that specializes in generative conversational AI tailored for the health and life sciences sectors. They invest globally at the Seed, Series A, and Series B stages, focusing on enhancing performance and engagement through AI solutions. Their partnerships include notable organizations such as NHS, Ministry of Defense, and Vanderbilt Health.
Avismo Ventures invests in startups developing domain-specific AI agents within the health and life sciences sectors. They provide capital and advisory services, particularly in Healthcare Professional engagement and training. Their investment range spans from Seed to Series B stages, targeting innovative solutions that improve AI interactions in healthcare.
Avismo Ventures has collaborated with significant healthcare organizations, including NHS, Ministry of Defense, Incyte, Vanderbilt Health, Almirall, Novo Nordisk, Astellas, and UCB. These partnerships highlight their commitment to advancing AI in the healthcare sector.
What stages does Avismo Ventures invest in?
Avismo Ventures invests in Seed, Series A, and Series B stages, focusing on startups in the health and life sciences sectors.
What is Avismo Ventures' primary investment focus?
The firm specializes in generative conversational AI solutions aimed at enhancing performance and engagement in healthcare and life sciences.
Does Avismo Ventures provide support beyond capital?
Yes, they offer advisory services related to Healthcare Professional engagement and training, in addition to their investment capital.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.